Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A circular trans-acting hepatitis delta virus ribozyme

M Puttaraju1, A T Perrotta, M D Been

  • 1Department of Biochemistry, Duke University Medical Center, Durham, NC 27710.

Nucleic Acids Research
|September 11, 1993
PubMed
Summary

Circular ribozymes, based on the hepatitis delta virus (HDV) motif, show comparable activity and enhanced stability against nucleases. Circularization offers a promising strategy for stabilizing ribozymes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Under-carboxylated osteocalcin regulates glucose and lipid metabolism during pregnancy and lactation in rats.

Journal of endocrinological investigation·2020
Same author

Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo.

Molecular therapy : the journal of the American Society of Gene Therapy·2008
Same author

A generalizable strategy for imaging pre-mRNA levels in living subjects using spliceosome-mediated RNA trans-splicing.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2008
Same author

Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery.

Molecular therapy : the journal of the American Society of Gene Therapy·2007
Same author

HDV ribozymes.

Current topics in microbiology and immunology·2006
Same author

Molecular imaging of gene expression in living subjects by spliceosome-mediated RNA trans-splicing.

Proceedings of the National Academy of Sciences of the United States of America·2004

Area of Science:

  • Molecular Biology
  • Biochemistry
  • RNA Therapeutics

Background:

  • Ribozymes are catalytic RNA molecules with therapeutic potential.
  • Hepatitis delta virus (HDV) ribozymes are well-characterized for their catalytic activity.
  • Stabilizing ribozymes against degradation is crucial for their application.

Purpose of the Study:

  • To produce and characterize a circular trans-acting ribozyme based on the HDV motif.
  • To assess the catalytic activity and nuclease resistance of the circular ribozyme.
  • To evaluate circularization as a stabilization strategy for ribozymes.

Main Methods:

  • In vitro production of a circular ribozyme via splicing of a modified group I intron precursor.
  • Assay of trans-cleavage activity of the circular ribozyme and linear controls.
  • Assessment of nuclease resistance in nuclear and cytoplasmic HeLa cell extracts.

Main Results:

  • A circular HDV-like ribozyme was successfully produced.
  • Trans-cleavage activity of the circular ribozyme was comparable to linear variants.
  • The circular ribozyme exhibited enhanced resistance to nuclease degradation compared to its linear counterpart.

Conclusions:

  • Circularization of HDV-like ribozymes maintains catalytic activity.
  • Circularization enhances ribozyme stability against cellular nucleases.
  • This suggests circularization is a viable alternative to chemical modification for ribozyme stabilization.

Related Experiment Videos